Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney TransplantAntibody-Mediated Rejection (AMR)Not yet recruitingPhase 22026-10-01NCT07613359

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Takeda163

35 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Beijing Friendship Hospital, Capital Medical UniversityBeijingChina64
CHU Bordeaux, CHU PellegrinBordeauxFrance2
CHU de Toulouse - Hopital RangueilToulouseFrance2
Cleveland Clinic - ClevelandClevelandUnited States4
Cooperman Barnabas Medical CenterLivingstonUnited States64
Froedtert and The Medical College of WisconsinMilwaukeeUnited States21
Hopital Edouard Herriot (HEH)LyonFrance1
Hopital Henri MondorCréteilFrance12
Intermountain HealthcareMurrayUnited States4
Japanese Red Cross Aichi Medical Center Nagoya Daini HospitalNagoyaJapan8
Japanese Red Cross Kumamoto HospitalKumamotoJapan6
Kaiser Permanente-San Francisco Medical Center - Kidney Transplant ClinicSan FranciscoUnited States1
Kliniken Universitatsklinikum Bochum GmbHBochumGermany1
Ludwig-Maximilians-Universitaet Muenchen (LMU) Klinikum der Universitaet MuenchenMünchenGermany1
Niigata University Medical and Dental HospitalNiigataJapan8
NYU Langone Health - Transplant AssociatesNew YorkUnited States1
Osaka Metropolitan University HospitalOsakaJapan3
Shandong Provincial Qianfoshan HospitalJinanChina2
Tampa General HospitalTampaUnited States128
The First Affiliated Hospital of Sun Yat-sen UniversityGuangdongChina2
The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anChina14
The First Affiliated Hospital of Zhejiang University school of medicineHangzhouChina18
The Second Affiliated Hospital of Guangxi Medical UniversityNanningChina5
Tongji Hospital Affiliated to Tongji Medicine UniversityWuhanChina1
UCLA University of California Los AngelesLos AngelesUnited States2